Apr. 15, 2020
Management / Financial Result
Product / Brand
Technology / R&D
CSR / Environment
About Production Start of Hand Sanitizer (Designated Quasi Drug)
-Production to start at 4 plants, promote further quantities in Japan-
Shiseido Company, Limited (“Shiseido”) has reviewed and taken various measures, making use of its knowledge, technologies and facilities, in a policy to “consider all possibilities available to us, as a cosmetics company, to suppress the spread of the Coronavirus infection and take immediate action.” (Shiseido President and CEO Masahiko Uotani)
Shiseido has uniquely developed a new hand sanitizer (designated quasi drug) with special attention to sensitive and raw hands, and will start production at its Nasu Factory (Ohtawara City, Tochigi Prefecture) from April 17 following consultation with the ministries involved. From May, the company will also start production at Osaka Factory, Kakegawa Factory and Kuki Factory, for a total monthly quantity of 200,000 bottles (approximately 100,000 liters) to be supplied mainly to medical institutes and facilities in Japan.
Furthermore, the company will disclose the information (formula) for this hand sanitizer, approved by the Ministry of Health, Labor and Welfare, for other companies to use in their production as well.
The company is also currently producing disinfectant solutions outside of Japan. In France, Shiseido EMEA produces about 20,000 bottles of hydroalcoholic gel per week at its Val de Loire Factory (Orléans), and in the United States, Shiseido Americas has also started production at East Windsor Factory (New Jersey) with a first production of 85,000 bottles, each supplied to medical institutions in their respective regions.
Shiseido will continue to provide various support in the effort to curb and bring a quick end to the spread of the Coronavirus.
*The content of the release is correct as of the time of release, but please note that it may in some cases differ from the latest information.